Parathyroid hormone

J Am Acad Orthop Surg. 2004 Mar-Apr;12(2):67-71. doi: 10.5435/00124635-200403000-00001.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Alendronate / therapeutic use
  • Bone Density / drug effects
  • Bone Remodeling / drug effects
  • Bone Remodeling / physiology
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Etidronic Acid / analogs & derivatives*
  • Etidronic Acid / therapeutic use
  • Female
  • Follow-Up Studies
  • Fractures, Spontaneous / prevention & control*
  • Humans
  • Male
  • Middle Aged
  • Osteoporosis / diagnosis
  • Osteoporosis / drug therapy
  • Osteoporosis, Postmenopausal / diagnosis
  • Osteoporosis, Postmenopausal / drug therapy*
  • Parathyroid Hormone / therapeutic use*
  • Risedronic Acid
  • Risk Assessment
  • Teriparatide / therapeutic use
  • Treatment Outcome

Substances

  • Parathyroid Hormone
  • Teriparatide
  • Risedronic Acid
  • Etidronic Acid
  • Alendronate